IRON
Disc Medicine, Inc.
$60.35
0.6
(1%)
| Exchange: | NASDAQ |
| Market Cap: | 2.098B |
| Shares Outstanding: | 4.53M |
About The Company
| Sector: | Healthcare | |||||
| Industry: | Biotechnology | |||||
| CEO: | John D. Quisel | |||||
| Full Time Employees: | 94 | |||||
| Address: |
|
|||||
| Website: | https://www.discmedicine.com |
Disc Medicine, Inc., a clinical-stage biotechnology company, engages in discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases. It builds a portfolio of therapeutic candidates that address a spectrum of hematologic diseases by targeting fundamental biological pathways of red blood cell biology, primarily heme biosynthesis and iron homeostasis. The company is based in Watertown, Massachusetts.
Click to read more…
Revenue Segmentation
🔒 You are currently logged out
Income Statement
(* All numbers are in thousands)
🔒 You are currently logged out
Balance Sheet
(* All numbers are in thousands)
🔒 You are currently logged out
Cash Flow Statement
(* All numbers are in thousands)
🔒 You are currently logged out
Analyst Estimates
(* All numbers are in thousands)
🔒 You are currently logged out
🔒 You are currently logged out
MS_Stock_Embed class not found. Please check plugin configuration.